Based in the Netherlands, GlycoTreat is a startup.
GlycoTreat develops glyco-immunology based allergen immunotherapy treatments that manipulate specific glycan structures to modulate the immune system and induce tolerance for allergic diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.